Colleen Silky

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

Miles Miller, Gary Look, Andrew F. Teich, 2014, PloS one.

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

Gary Look, Ottavio Arancio, Chenbo Zeng, 2014, PloS one.

Abstracts of 20th Annual ASENT Meeting

K. Blennow, M. Grundman, R. Guilbaud, 2018, Neurotherapeutics.

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

R. Mach, A. Goate, C. Cruchaga, 2014, PloS one.

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

Miles C. Miller, G. Rishton, O. Arancio, 2014, PloS one.